CapitaLand Hope Foundation will match donations, up to S$200,000, and all proceeds will go to ART:DIS, Metta Welfare Association, MINDS, Rainbow Centre and TOUCH Community Services to support skills development initiatives for youths with special needs. #csr #artjam #community
Follow
Hummingbird Bioscience
@hummingbirdbio
Hummingbird Bioscience is an innovative clinical-stage biotech company with operations in Singapore and the US.
Hummingbird Bioscience’s Tweets
The inaugural program involves the painting of 40 picnic benches by the Singapore Science Park community and talents with disabilities. These benches will be placed around the Park.
1
Show this thread
Hummingbird Bioscience participated in Development's community initiative, Art Jam Science Park: Bench Art edition by adopting a bench and painting it with beneficiaries of the initiative on 29 May. Check out our bench designed by TOUCH special artist, Yew Ping!
1
Show this thread
Hummingbird Bioscience will be presenting a Trials in Progress Poster for HMBD-002 at Annual Meeting 2023. #asco2023
Read more: bit.ly/3BTyCMF
1
Hummingbird Bioscience will be at BIO International Convention this June. Find us in the BIO’s One-on-One Partnering System to schedule a meeting. We look forward to partnering.
#StandUpForScience #BIO2023
1
HMBD-011 represents a potentially important new therapy for patients with cold agglutinin disease.
Read our feature in Cold Agglutinin Disease News here:
Hummingbird Bioscience is featured in 's article on the new wave of therapeutic antibodies, led by the rise of AI and the increased cross-discipline collaboration over the years: bit.ly/3WiQ6vk
#ADC #drugdiscovery
1
1
Hummingbird Bioscience and Merck enter collaboration to evaluate HMBD-001 in squamous non-small cell lung carcinoma. Press release: bit.ly/44yJgFo
1
Read our press release on HMBD-011, a potentially first-in-class anti-VH4-34 antibody developed for treatment of autoimmune diseases including lupus here:
bit.ly/3LYDGFc
#immunology #immunology2023 #AAI2023
1
Show this thread
This #WorldLupusDay, show your support to people affected by lupus by wearing purple and check out further resources at:
1
Show this thread
May is #LupusAwarenessMonth. Globally, millions of people are affected by #lupus. The symptoms of the disease may not be visible, however, its impact can be wide-ranging for affected individuals.
0:08
22 views
1
1
Show this thread
Hummingbird Bioscience will present preclinical proof of concept for HMBD-011 at IMMUNOLOGY2023™.
Press release: bit.ly/3LYDGFc
#immunology #immunology2023 #AAI2023
1
We are delighted to share that we are #GPTWCertified. The certification is a testament to our great workplace culture, and we will strive to continuously improve. Check out our Great Place To Work-Certified™ company profile: bit.ly/3HxcjQ5
1
Hummingbird Bioscience will present two posters on HER3-Targeting Therapeutics at Meeting 2023. Press release: bit.ly/3LnAL9c
#AACR23
Through this event, we hope we have helped to demystify drug discovery and development.
Connect with us to explore CSR partnerships: csr@hummingbirdbio.com
Show this thread
The event, organized by the MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Community Outreach Student Organization, hosts live science demonstrations which aim to excite the youth about science.
1
Show this thread
A month ago, Hummingbird Bioscience provided educational materials about the discovery and development of cancer therapeutics at Science Night 2023 in Houston.
1
Show this thread
In line with Science Education Day, observed on 14 March annually in the U.S., Hummingbird Bioscience is committed to supporting science education. Science education is critical in helping youth develop some of the most in-demand skills of the 21st century.
1
Show this thread
Akshaya Bansal, Manager, Antibody-Drug Conjugates, Hummingbird Bioscience, shares about providing greater access to resources to help decrease the digital gender gap:
1
Show this thread
Sara Haghani, Research Associate 2, Computational Biology & Bioinformatics, Hummingbird Bioscience, shares the importance of encouraging young girls to pursue tech-related fields:
1
Show this thread
Leah DiMascio, Chief Development Officer, Hummingbird Bioscience, shares how having visible female role models can help close the digital gender gap:
1
Show this thread
Hummingbird Bioscience has exercised its option to license in the first-in-human clinical trial results of HMBD-001, a differentiated and potentially best-in-class HER3-targeting antibody, from
Press release: bit.ly/3IVc7dh
2
We hope that our contributions have made a positive impact on the community.
1
Show this thread
The initiative is part of a larger program (Adopt @ South West) by the South West CDC, to provide well-rounded assistance in the areas of social support & wellness, education & enrichment, and home maintenance & improvement.
1
1
Show this thread
Our CSR committee and volunteers planned the event with CDC, then packed and distributed bags of food and necessities to households in Telok Blangah.
1
Show this thread
For the second year running, Hummingbird Bioscience collaborated with South West Community Development Council and People’s Association to give back to the community on 25th February 2023.
1
1
Show this thread
Hummingbird Bioscience will participate at upcoming #investor conferences: the 43rd Annual Cowen Healthcare Conference and Mizuho’s Inaugural Oncology Therapeutics Summit.
2
2
The new horizon for HER3 treatments: HER3 ADCs
Hummingbird Bioscience adopts a biomarker-driven approach with HMBD-001 (HER3 mAb) and HMBD-501 (HER3 ADC) to provide the most optimal treatment for patients.
Read more:
1
1
Hummingbird Bioscience and today announced a licensing agreement that will enable development of a next generation ADC program. Read more: buff.ly/3WIwyzN
1
2
1
Show this thread
Hummingbird Bioscience and today announced a strategic collaboration to advance clinical development of Hummingbird Bioscience’s anti-HER3 therapy, HMBD-001. Read more: bit.ly/3XSCirA
1
This Extraordinary Work Team Recognition Day, we would like to thank our team for their commitment to excellence over the years that has brought our programs to clinic. Catch a snippet of our company dinner celebrations here:
We are delighted to share that we have won Startup Of The Year 2022 (Special Jury Recognition) at the Excellence Awards 2022.
Read more: bit.ly/3GHXTwM
AI is revolutionizing drug discovery, and its full potential has yet to be reached. @Pharma_Intell In Vivo and featured in an analysis of AI-enabled biologics projects. Read more about this emerging frontier: bit.ly/3fPVRjb
1
Trials In Progress Poster: 623
When: Thursday, November 10, 2022 (9am to 9pm ET)
Preclinical Poster: 532
When: Friday, November 11, 2022 (9am to 830pm ET)
Show this thread
We look forward to discussing longer-term clinical development plans and combination strategies with the wider immuno-oncology community at —meet us at Hall C.
1
Show this thread
Hummingbird Bioscience will present two poster presentations for HMBD-002, a potential first-in-class anti-VISTA antibody, at the 37th Annual Meeting of the . Read more: bit.ly/3fqhlTH
1
1
Show this thread
Chief Financial Officer Josh House and Chief Development Officer Leah DiMascio will attend the Credit Suisse 31st Annual Global Healthcare Conference (November 7 - 10, 2022) and participate in one-on-one investor meetings.
Press release: bit.ly/3TSemlE
